Back to results
US 2024/0425542 A1Published application
Cyclic deoxyribonucleotide compounds
AssigneeNucorion Pharmaceuticals, Inc.
InventorLin Zhi
Life of this patent
Estimating the term…
Abstract
Provided herein are 5-fluorouracil derived cyclic deoxyribonucleotide compounds, their preparation and their uses, such as treating liver diseases or various types of cancer.
Claims14
A method of treatment, comprising:
- conducting a medical procedure;
- and
- administering a compound of Formula I, Ia, or II:
- or a stereoisomer or a pharmaceutically acceptable salt thereof,
- wherein:
- R1 is selected from the group consisting of H, halo, C1-C10 alkyl, —O—C1-6 alkyl, —O-carboxy, —OCH2OR9, —CH(OR9)2, —C-carboxy, —C-amido, —CH2OCH2OR9,
- and —CH2O-carboxy;
- each R2 is independently H, halo, or a C1-C10 alkyl;
- R3 is selected from the group consisting of —O-carboxy, —OCH2OR9, —CH(OR9)2, —C-carboxy, —C-amido, —CH2OCH2OR9,
- —CH2O-carboxy, C1-C10 alkyl, and C3-C10 cycloalkyl;
- R4 is an optionally substituted C1-C10 alkyl;
- each R5 and R6 are independently H or a C1-C10 alkyl;
- or alternatively, an R5 and R6 attached to the same carbon atom may be taken together with the atom to which they are attached form a C3-C10 cycloalkyl;
- each R7 and R8 are independently H or a C1-C10 alkyl;
- or alternatively, an R7 and R8 attached to the same carbon atom may be taken together with the atom to which they are attached form a C3-C10 cycloalkyl;
- and
- R9 is an optionally substituted C1-C10 alkyl;
- provided that the compound is not selected from:
15 more elements
A method of treating a disease, disorder or condition comprising administering an effective amount of a compound of Formula I, Ia, or II:
- or a stereoisomer or a pharmaceutically acceptable salt thereof,
- wherein:
- R1 is selected from the group consisting of H, halo, C1-C10 alkyl, —O-C1-6 alkyl, —O-carboxy, —OCH2OR9, —CH(OR9)2, —C-carboxy, —C-amido, —CH2OCH2OR9,
- and-CH2O-carboxy;
- each R2 is independently H, halo, or a C1-C10 alkyl;
- R3 is selected from the group consisting of —O-carboxy, —OCH2OR9, —CH(OR9)2, —C-carboxy, —C-amido, —CH2OCH2OR9,
- —CH2O-carboxy, C1-C10 alkyl, and C3-C10 cycloalkyl;
- R4 is an optionally substituted C1-C10 alkyl;
- each R5 and R6 are independently H or a C1-C10 alkyl;
- or alternatively, an R5 and R6 attached to the same carbon atom may be taken together with the atom to which they are attached form a C3-C10 cycloalkyl;
- each R7 and R8 are independently H or a C1-C10 alkyl;
- or alternatively, an R7 and R8 attached to the same carbon atom may be taken together with the atom to which they are attached form a C3-C10 cycloalkyl;
- and
- R9 is an optionally substituted C1-C10 alkyl;
- provided that the compound is not selected from:
- to a subject in need thereof wherein the disease, disorder, or condition is cancer in the liver.
13 more elements
Dependencies are inferred from the claim text.